All Articles

Family safety app Life360 acquires ad-tech firm Nativo, using its vast location data to build an ad empire. Can it balance profit with user privacy?

A new joint venture between Corewell Health and Quest Diagnostics aims to reshape lab services across Michigan with a new high-tech facility and new efficiencies.

With Talya Nevo-Hacohen retiring, veteran Darrin Smith takes the helm as CIO. How will his vision shape Sabra's portfolio in a dynamic healthcare REIT market?

Priestly Demolition appoints an external CEO and promotes internal leaders, a strategic move to blend new expertise with its family legacy for major expansion.

JetBlue is adding year-round flights to Dallas and Orlando from Fort Lauderdale, sparking new competition and promising more options for Florida travelers.

DIETL's acquisition of four specialists, including a rare US freeport, signals a major consolidation in the elite world of fine art logistics.

Activist investor YZi Labs accuses CEA Industries of entrenchment after it adopted a 'poison pill,' escalating a battle over board control and crypto strategy.

KIOXIA's new BG7 SSDs use breakthrough BiCS FLASH Gen 8 and CBA tech to deliver major speed and power efficiency gains for the next generation of PCs.

A new health initiative aims to fight chronic disease with personalized nutrition. But can data from your body truly fix a broken food system?

As media giants face a fragmented ad landscape, Operative's new AOS Services Platform aims to unify linear and digital revenue with an AI-driven core.

As it marks 32 years, Alexandria Real Estate Equities proves its resilience, dominating the market it created amid industry-wide headwinds.

At CES 2026, Ubicept's new toolkit promises to let AI see clearly in the dark and at high speed, ushering in a new era for robotics and autonomous cars.

Lucid crushed its 2025 production goals with a huge Q4 surge, but a widening gap between cars built and sold raises serious questions about demand.

BridGene Biosciences adds Nobel winner Dr. Bruce Beutler to its board, gaining immense credibility for its mission to create drugs for intractable diseases.

A new initiative is tackling the fear and distrust that costs patients their health and the system trillions. Is 'cognitive safety' healthcare's next frontier?

Fintech firm Movemint's rebrand signals a major shift for banks, focusing on embedded finance and personalized experiences to drive measurable growth.

Founder Chuck Cohn pours millions more into his ed-tech firm, a bold move that signals deep confidence despite a slumping stock and cautious analysts.

With a hot obesity pipeline and a key neurology asset, Nxera Pharma's J.P. Morgan talk is a crucial test of its plan for global leadership.

William Healey, a 25-year veteran, takes the helm as IAAO's 2026 President, guiding the future of global property valuation amid technological change.

With a $257M war chest and a veteran team, BlossomHill will showcase its innovative pipeline for lung cancer and leukemia at the pivotal JPM conference.